GenMark Diagnostics (NASDAQ: GNMK) reported Q4 EPS of ($0.21), $0.06 better than the analyst estimate of ($0.27). Revenue for the quarter came in at $13.2 million versus the consensus estimate of $12.3 million.

For earnings history and earnings-related data on GenMark Diagnostics (GNMK) click here.